Association Between Acute Gastroenteritis and Continuous Use of Proton Pump Inhibitors During Winter Periods of Highest Circulation of Enteric Viruses
In: EISSN: 2574-3805 ; JAMA Network Open ; https://hal.sorbonne-universite.fr/hal-03863437 ; JAMA Network Open, 2023, 2023
Online
academicJournal
Zugriff:
International audience ; Importance: An increased risk of acute bacterial enteric infections has been reported among patients receiving proton pump inhibitor (PPI) therapy. The risk of acute gastroenteritis (AGE) of viral origin associated with continuous PPI exposure has been less studied.Objective: To investigate the association between continuous PPI therapy and AGE occurrence during winter epidemic periods when the circulation of enteric viruses is the highest.Design, setting, and participants: A matched cohort study was performed using a prospectively collected drug dispensing database from a large panel of community pharmacies in continental France. All patients recorded in the database during the 2015 to 2016 winter season, with documented age, sex, and use of an identifiable regular panel pharmacy, were eligible for the study. Each patient exposed to continuous PPI therapy was matched to 3 unexposed patients, according to year of birth, sex, and identifiable regular panel pharmacy. Analyses were performed between January 2017 and December 2018.Exposure: Continuous PPI use during the 2015 to 2016 AGE winter epidemic.Main outcomes and measures: The occurrence of at least 1 AGE episode during the 2015 to 2016 AGE winter epidemic was the main outcome. Episodes of AGE were identified using a previously validated algorithm based on drug dispensing data. Relative risks of AGE were estimated using a multivariable log-binomial model adjusted for age, sex, and treatments for chronic conditions.Results: There were 233 596 patients receiving PPI therapy (median [interquartile range] age, 71 [62-81] years; 55.8% female) and 626 887 matched patients not receiving PPI therapy (median [interquartile range] age, 70 [61-80] years; 56.3% female) included in the analyses. At least 1 AGE epidemic episode was identified in 3131 patients (1.3%) receiving PPI therapy and in 4327 patients (0.7%) not receiving PPI therapy. The adjusted relative risk of AGE for those receiving PPI therapy was 1.81 (95% CI, 1.72-1.90) for all ages ...
Titel: |
Association Between Acute Gastroenteritis and Continuous Use of Proton Pump Inhibitors During Winter Periods of Highest Circulation of Enteric Viruses
|
---|---|
Autor/in / Beteiligte Person: | Vilcu, Ana-Maria ; Sabatte, Laure ; Blanchon, Thierry ; Souty, Cécile ; Maravic, Milka ; Lemaitre, Magali ; Steichen, Olivier ; Hanslik, Thomas ; Institut Pierre Louis d'Epidémiologie et de Santé Publique (iPLESP) ; Institut National de la Santé et de la Recherche Médicale (INSERM)-Sorbonne Université (SU) ; CHU Saint-Antoine AP-HP ; Assistance publique - Hôpitaux de Paris (AP-HP) (AP-HP)-Sorbonne Université (SU) ; IQVIA ; Hôpital Lariboisière-Fernand-Widal, APHP ; Assistance publique - Hôpitaux de Paris (AP-HP) (AP-HP) ; CHU Tenon AP-HP ; Laboratoire d'Informatique Médicale et Ingénierie des Connaissances en e-Santé (LIMICS) ; Institut National de la Santé et de la Recherche Médicale (INSERM)-Sorbonne Université (SU)-Université Sorbonne Paris Nord ; Université de Versailles Saint-Quentin-en-Yvelines (UVSQ) ; Hôpital Ambroise Paré AP-HP |
Link: | |
Zeitschrift: | EISSN: 2574-3805 ; JAMA Network Open ; https://hal.sorbonne-universite.fr/hal-03863437 ; JAMA Network Open, 2023, 2023 |
Veröffentlichung: | HAL CCSD ; American Medical Association, 2023 |
Medientyp: | academicJournal |
DOI: | 10.1001/jamanetworkopen.2019.16205 |
Schlagwort: |
|
Sonstiges: |
|